Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
Цены на нефть взлетели до максимума за полгода17:55，推荐阅读同城约会获取更多信息
Netflix and Max bundle (with ads)，推荐阅读搜狗输入法2026获取更多信息
The court of appeal has rejected the latest challenge to the addition of VAT to private school fees, telling parents they have the option to home school their children if they object to sending them to state schools.